神经系统疾病中的ISR调节器
Alexander Pavlovich Kalinin1, Ekaterina Sergeevna Zubkova1, Mikhail Yuryevich Menshikov1
1National Medical Research Centre of Cardiology Named after Academician E.I. Chazov, Ministry of Health of the Russian Federation, Moscow, Russia.
Current neuropharmacology
|February 25, 2025
概括
综合应激反应 (ISR) 途径在神经疾病中至关重要. 调节ISR信号为这些疾病提供了一个有前途的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 细胞压力与神经系统疾病的发病有关.
- 综合应激反应 (ISR) 是一种保存的细胞机制来应对压力.
- 功能障碍的ISR可以导致细胞亡,从而导致疾病的进展.
研究的目的:
- 审查ISR信号在神经疾病中的作用.
- 探索ISR调节器作为神经系统疾病的潜在治疗剂.
主要方法:
- 对ISR信号传递和神经系统疾病的现有文献的综述.
- 对调节ISR通路组件 (激酶,eIF2α) 的化合物进行分析.
主要成果:
- ISR激活涉及eIF2α通过PERK,HRI,PKR和GCN2等激酶的酸化.
- 伊斯尔调节蛋白质合成,有利于特定的转录因子 (ATF3,ATF4,CEBPA,CEBPB).
- 已经开发出了针对途径不同阶段的各种ISR调制器.
结论:
- 在神经疾病的发病过程中,ISR扮演着重要的角色.
- 针对ISR提供了一个新的治疗途径来治疗神经系统疾病.
- 开发安全有效的ISR向药物是迫切需要的.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
209
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
209
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Parkinson's Disease: Overview
424
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
424
Brain Imaging
203
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
203


